Stereotactic Radiosurgery for Primary Central Nervous System Lymphoma: Results From the International Radiosurgery Research Foundation

医学 放射外科 中枢神经系统 原发性肿瘤 放射科 基础(证据) 中枢神经系统疾病 伽玛刀 脑瘤 医学物理学 核医学
作者
Trent Shane Kite,Rodney E. Wegner,Steven Karlovits,John Herbst,John Lister,Henry Knox,Joshua David Palmer,Eugene Yap,David Bailey,Mariana Dejuk,Sean S. Mahase,Brad E. Zacharia,Christian Amezquita-Contreras,Angel I. Blanco,Yoshua Esquenazi,Ronald E. Warnick,Keiss Douri,David Mathieu,Manjul Tripathi,Narendra Kumar
出处
期刊:Neurosurgery [Lippincott Williams & Wilkins]
卷期号:99 (4): 820-829 被引量:1
标识
DOI:10.1227/neu.0000000000003903
摘要

BACKGROUND AND OBJECTIVES: Stereotactic radiosurgery (SRS) has been increasingly employed in the multimodal management of primary central nervous system lymphoma. Here, we evaluate the outcomes of SRS for the treatment of primary central nervous system lymphoma through a multicenter, international cohort study. METHODS: A multicenter, retrospective cohort study was conducted through the International Radiosurgery Research Foundation. Subgroups were defined according to treatment setting: up-front (primary treatment), boost (SRS after consolidative chemotherapy with or without whole-brain radiotherapy), and relapsed/refractory (recurrent/progressive disease after first-line therapy). The primary end point was local tumor control. Time-to-event analysis was conducted using the Kaplan-Meier method. Variables associated with local control were assessed using the Cox proportional hazard modeling. RESULTS: Fifty-four patients with 127 tumor sites were included in this analysis. Actuarial 12-month local and distant control rates for the entire cohort were 75.7% and 63.7%, respectively, with a median overall survival (OS) of 18 months (range: 1-176). Actuarial 12-month local control rates were significantly different at 95.6%, 78.3%, and 42.1% ( P < .0001) for the up-front, relapsed/refractory groups, and boost cohorts, respectively. OS across all cohorts were similar with 12-month OS rates of 55.2%, 51.3%, and 53.5% for the up-front, relapsed/refractory, and boost cohorts, respectively. Rates of radiation necrosis were 18.5%, 20.8%, 15.4%, and 11.8% for the entire cohort, relapsed/refractory, boost, and up-front cohorts, respectively. Diminished OS was significantly associated with treatment volumes >27 cm 3 (hazard ratio: 2.5, P = .04). CONCLUSION: SRS shows promising local tumor control rates for up-front and relapsed cohorts. Despite this, distant tumor progression limits total tumor control and may adversely affect OS.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
十三完成签到,获得积分10
刚刚
多多发布了新的文献求助10
刚刚
1秒前
小马甲的应助被九七采纳,获得30
1秒前
zhangruidan1完成签到 ,获得积分10
1秒前
2秒前
能不能给我来篇SSCI关注了科研通微信公众号
2秒前
2秒前
Tulip发布了新的文献求助10
2秒前
3秒前
FashionBoy的应助被September采纳,获得10
3秒前
会烧白开水完成签到 ,获得积分10
4秒前
星辰大海发布了新的文献求助10
4秒前
吴佳欣发布了新的文献求助20
4秒前
6秒前
昏昏欲睡完成签到 ,获得积分10
6秒前
7秒前
清爽的疾完成签到,获得积分20
8秒前
清晨五点的沙滩完成签到,获得积分10
8秒前
SciGPT的应助被不过尔尔采纳,获得10
8秒前
Lucas的应助被MingQue采纳,获得10
9秒前
9秒前
9秒前
10秒前
阿枫完成签到,获得积分10
10秒前
呼呼完成签到 ,获得积分10
11秒前
彭于晏的应助被bone采纳,获得10
11秒前
lxy完成签到,获得积分10
12秒前
彬彬完成签到 ,获得积分10
12秒前
粥粥完成签到,获得积分10
13秒前
3123939715发布了新的文献求助10
13秒前
科研通AI6.3的应助被时平谊采纳,获得10
13秒前
lcj发布了新的文献求助10
13秒前
CarryLJR的应助被小一班www采纳,获得10
14秒前
何梓桐发布了新的文献求助10
14秒前
abc关闭了abc的文献求助
14秒前
soda完成签到,获得积分10
15秒前
111完成签到,获得积分10
16秒前
无花果的应助被Li采纳,获得10
16秒前
MLi发布了新的文献求助10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178866
求助须知:如何正确求助?哪些是违规求助? 9569638
关于积分的说明 21805411
捐赠科研通 7774048
什么是DOI,文献DOI怎么找? 3432955
关于科研通互助平台的介绍 2556873
邀请新用户注册赠送积分活动 2478628